ProShare Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,265
| Closed | -$240K | – | 2037 |
|
|
2024
Q1 | $240K | Buy |
15,265
+1,299
| +9% | +$20K | ﹤0.01% | 1563 |
|
|
2023
Q4 | $225K | Buy |
13,966
+2,009
| +17% | +$25.6K | ﹤0.01% | 1572 |
|
|
2023
Q3 | $152K | Buy |
11,957
+63
| +0.5% | +$869 | ﹤0.01% | 1546 |
|
|
2023
Q2 | $167K | Buy |
11,894
+548
| +5% | +$7.84K | ﹤0.01% | 1578 |
|
|
2023
Q1 | $175K | Sell |
11,346
-159
| -1% | -$2.65K | ﹤0.01% | 1491 |
|
|
2022
Q4 | $189K | Buy |
11,505
+918
| +9% | +$14.9K | ﹤0.01% | 1515 |
|
|
2022
Q3 | $196K | Buy |
10,587
+368
| +4% | +$5.78K | ﹤0.01% | 1420 |
|
|
2022
Q2 | $135K | Sell |
10,219
-3,296
| -24% | -$36.4K | ﹤0.01% | 1558 |
|
|
2022
Q1 | $125K | Sell |
13,515
-3,318
| -20% | -$28.2K | ﹤0.01% | 1990 |
|
|
2021
Q4 | $164K | Sell |
16,833
-609
| -3% | -$11.5K | ﹤0.01% | 2096 |
|
|
2021
Q3 | $593K | Sell |
17,442
-3,184
| -15% | -$102K | ﹤0.01% | 1105 |
|
|
2021
Q2 | $755K | Buy |
20,626
+2,341
| +13% | +$90.6K | ﹤0.01% | 1220 |
|
|
2021
Q1 | $820K | Buy |
18,285
+1,050
| +6% | +$48.9K | ﹤0.01% | 1111 |
|
|
2020
Q4 | $984K | Buy |
17,235
+3,563
| +26% | +$211K | ﹤0.01% | 889 |
|
|
2020
Q3 | $701K | Sell |
13,672
-337
| -2% | -$16.5K | ﹤0.01% | 821 |
|
|
2020
Q2 | $837K | Buy |
14,009
+5,755
| +70% | +$308K | ﹤0.01% | 766 |
|
|
2020
Q1 | $340K | Sell |
8,254
-5,449
| -40% | -$303K | ﹤0.01% | 840 |
|
|
2019
Q4 | $853K | Sell |
13,703
-1,729
| -11% | -$82.2K | ﹤0.01% | 852 |
|
|
2019
Q3 | $524K | Buy |
15,432
+3,356
| +28% | +$99.3K | ﹤0.01% | 964 |
|
|
2019
Q2 | $272K | Sell |
12,076
-1,674
| -12% | -$39.2K | ﹤0.01% | 1298 |
|
|
2019
Q1 | $319K | Buy |
13,750
+58
| +0.4% | +$1.52K | ﹤0.01% | 1224 |
|
|
2018
Q4 | $287K | Buy |
+13,692
| New | +$337K | ﹤0.01% | 1185 |
|
Other funds holding DCPH
ProShare Advisors's DCPH Position: Q2 2024 in Review
ProShare Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 15,265 shares — an estimated $240K sold.
ProShare Advisors first reported a position in DCPH in Q4 2018 and held it in 22 quarters. The position peaked at $984K in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- ProShare Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- ProShare Advisors sold 15,265 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $240K.
- ProShare Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 22 quarters.
- ProShare Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $984K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.